{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:36:43Z","timestamp":1792420603204,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"\"National Institute of Health\" research project","doi-asserted-by":"crossref","award":["2014-ER6301-00, 2014-ER6301-01, 2014-ER6301-02, 2017-ER6301-00, 2017-ER6301-01, and 2017-ER6301-02"],"award-info":[{"award-number":["2014-ER6301-00, 2014-ER6301-01, 2014-ER6301-02, 2017-ER6301-00, 2017-ER6301-01, and 2017-ER6301-02"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"\"National Institute of Health\" research project","doi-asserted-by":"crossref","award":["2014-ER6301-00, 2014-ER6301-01, 2014-ER6301-02, 2017-ER6301-00, 2017-ER6301-01, and 2017-ER6301-02"],"award-info":[{"award-number":["2014-ER6301-00, 2014-ER6301-01, 2014-ER6301-02, 2017-ER6301-00, 2017-ER6301-01, and 2017-ER6301-02"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003670","name":"National Evidence-based Healthcare Collaborating Agency","doi-asserted-by":"publisher","award":["NA-21-002"],"award-info":[{"award-number":["NA-21-002"]}],"id":[{"id":"10.13039\/501100003670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cytomegalovirus (CMV) infection is a frequent complication after kidney transplantation (KT) and has various effects on recipient and graft survival. Although guidelines recommend anti-viral prophylaxis with ganciclovir or valganciclovir, there is a demand for alternative regimen for CMV prevention. We investigated the effects of a 3-month valacyclovir-based prophylaxis on CMV infection and clinical outcomes in KT recipients using a nationwide cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Overall, 2,584 KT recipients from 20 transplant centers registered with the Korean Organ Transplantation Registry between May 2014 and December 2019 were analyzed in this study. The recipients were divided into valacyclovir prophylaxis and non-prophylaxis groups, a 1:3 propensity score matching was performed, and 1,036 recipients (291 and 745 in the prophylaxis and non-prophylaxis groups, respectively) were analyzed. The impact of valacyclovir-based prophylaxis on CMV after KT, other clinical outcomes, and the risk factors for CMV infection development were investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The prophylaxis group showed a lower incidence of CMV infection and rejection compared to the non-prophylaxis group (3.64 vs. 10.25 events\/100 person-years and 1.85 vs. 7.27 events\/100 person-years, respectively). Valacyclovir prophylaxis, donor age, deceased donor, length of hospitalization after KT, anti-thymocyte globulin use, and CMV serological mismatch between the donor and recipient were independent risk factors for CMV infection after KT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Valacyclovir prophylaxis after KT significantly reduced CMV infection and rejection. We suggest that valacyclovir could be considered as an alternative strategy for CMV prophylaxis after KT. However, our study has limitations, including its retrospective design, variability in valacyclovir dosing and CMV monitoring, and unassessed confounding factors. Further prospective studies with standardized protocols and larger cohorts are needed to validate our findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-10671-6","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T09:57:47Z","timestamp":1741168667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Valacyclovir for the prevention of cytomegalovirus infection after kidney transplantation"],"prefix":"10.1186","volume":"25","author":[{"given":"Jin Sug","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Rae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyun-Ik","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Seok","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ha","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Woong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang-Hee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Yeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Cheol","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeseok","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Berm","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jin Na","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Eun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deok Gie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Sik","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hyun","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hwan","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"KOTRY study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"issue":"Suppl 4","key":"10671_CR1","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1111\/j.1600-6143.2009.02897.x","volume":"9","author":"A Humar","year":"2009","unstructured":"Humar A, Snydman D, Practice ASTIDCo. Cytomegalovirus in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S78-86.","journal-title":"Am J Transplant"},{"issue":"4","key":"10671_CR2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1681\/ASN.V124848","volume":"12","author":"DC Brennan","year":"2001","unstructured":"Brennan DC. Cytomegalovirus in renal transplantation. J Am Soc Nephrol. 2001;12(4):848\u201355.","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10671_CR3","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.2215\/CJN.02900707","volume":"3","author":"BC Weikert","year":"2008","unstructured":"Weikert BC, Blumberg EA. Viral infection after renal transplantation: surveillance and management. Clin J Am Soc Nephrol. 2008;3(Suppl 2):S76-86.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10671_CR4","first-page":"74","volume":"3","author":"B Einollahi","year":"2012","unstructured":"Einollahi B. Cytomegalovirus Infection following Kidney Transplantation: a Multicenter Study of 3065 Cases. Int J Organ Transplant Med. 2012;3(2):74\u20138.","journal-title":"Int J Organ Transplant Med"},{"issue":"9","key":"10671_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1469-0691.2005.01215.x","volume":"11","author":"ID Pavlopoulou","year":"2005","unstructured":"Pavlopoulou ID, Syriopoulou VP, Chelioti H, Daikos GL, Stamatiades D, Kostakis A, Boletis JN. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients. Clin Microbiol Infect. 2005;11(9):736\u201343.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10671_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.ajkd.2011.04.010","volume":"58","author":"K De Keyzer","year":"2011","unstructured":"De Keyzer K, Van Laecke S, Peeters P, Vanholder R. Human cytomegalovirus and kidney transplantation: a clinician\u2019s update. Am J Kidney Dis. 2011;58(1):118\u201326.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10671_CR7","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.2215\/CJN.04410512","volume":"7","author":"S Karuthu","year":"2012","unstructured":"Karuthu S, Blumberg EA. Common infections in kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7(12):2058\u201370.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"24","key":"10671_CR8","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","volume":"338","author":"JA Fishman","year":"1998","unstructured":"Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741\u201351.","journal-title":"N Engl J Med"},{"issue":"8","key":"10671_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2165\/10898540-000000000-00000","volume":"70","author":"AJ Eid","year":"2010","unstructured":"Eid AJ, Razonable RR. New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs. 2010;70(8):965\u201381.","journal-title":"Drugs"},{"issue":"3","key":"10671_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/TP.0b013e318192ded5","volume":"87","author":"T Reischig","year":"2009","unstructured":"Reischig T, Jindra P, Hes O, Bouda M, Kormunda S, Treska V. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis. Transplantation. 2009;87(3):436\u201344.","journal-title":"Transplantation"},{"issue":"5","key":"10671_CR11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nefro.2016.11.018","volume":"37","author":"MO Lopez-Oliva","year":"2017","unstructured":"Lopez-Oliva MO, Flores J, Madero R, Escuin F, Santana MJ, Bellon T, Selgas R, Jimenez C. Cytomegalovirus infection after kidney transplantation and long-term graft loss. Nefrologia. 2017;37(5):515\u201325.","journal-title":"Nefrologia"},{"issue":"3","key":"10671_CR12","doi-asserted-by":"publisher","first-page":"e13080","DOI":"10.1111\/tid.13080","volume":"21","author":"MR Jorgenson","year":"2019","unstructured":"Jorgenson MR, Descourouez JL, Cardinale B, Lyu B, Astor BC, Garg N, Saddler CM, Smith JA, Mandelbrot DA. Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes. Transpl Infect Dis. 2019;21(3):e13080.","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10671_CR13","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1007\/s00125-004-1499-z","volume":"47","author":"J Hjelmesaeth","year":"2004","unstructured":"Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia. 2004;47(9):1550\u20136.","journal-title":"Diabetologia"},{"issue":"2","key":"10671_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00007890-200007270-00013","volume":"70","author":"A Humar","year":"2000","unstructured":"Humar A, Gillingham K, Payne WD, Sutherland DE, Matas AJ. Increased incidence of cardiac complications in kidney transplant recipients with cytomegalovirus disease. Transplantation. 2000;70(2):310\u20133.","journal-title":"Transplantation"},{"issue":"2","key":"10671_CR15","doi-asserted-by":"publisher","first-page":"e13483","DOI":"10.1111\/tid.13483","volume":"23","author":"AD Raval","year":"2021","unstructured":"Raval AD, Kistler KD, Tang Y, Murata Y, Snydman DR. Epidemiology, risk factors, and outcomes associated with cytomegalovirus in adult kidney transplant recipients: A systematic literature review of real-world evidence. Transpl Infect Dis. 2021;23(2):e13483.","journal-title":"Transpl Infect Dis."},{"issue":"2","key":"10671_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1053\/j.ajkd.2010.04.010","volume":"56","author":"M Bia","year":"2010","unstructured":"Bia M, Adey DB, Bloom RD, Chan L, Kulkarni S, Tomlanovich S. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Kidney Dis. 2010;56(2):189\u2013218.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10671_CR17","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, Humar A, The Transplantation Society International CMVCG. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation. 2018;102(6):900\u201331.","journal-title":"Transplantation"},{"issue":"9","key":"10671_CR18","doi-asserted-by":"publisher","first-page":"e13512","DOI":"10.1111\/ctr.13512","volume":"33","author":"RR Razonable","year":"2019","unstructured":"Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13512.","journal-title":"Clin Transplant."},{"issue":"10","key":"10671_CR19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1056\/NEJM199609053351007","volume":"335","author":"CS Crumpacker","year":"1996","unstructured":"Crumpacker CS. Ganciclovir. N Engl J Med. 1996;335(10):721\u20139.","journal-title":"N Engl J Med"},{"issue":"19","key":"10671_CR20","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","volume":"340","author":"D Lowance","year":"1999","unstructured":"Lowance D, Neumayer HH, Legendre CM, Squifflet JP, Kovarik J, Brennan PJ, Norman D, Mendez R, Keating MR, Coggon GL, et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med. 1999;340(19):1462\u201370.","journal-title":"N Engl J Med"},{"issue":"2","key":"10671_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2215\/CJN.07020714","volume":"10","author":"T Reischig","year":"2015","unstructured":"Reischig T, Kacer M, Jindra P, Hes O, Lysak D, Bouda M. Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. Clin J Am Soc Nephrol. 2015;10(2):294\u2013304.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10671_CR22","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1432-2277.2002.tb00120.x","volume":"15","author":"T Reischig","year":"2002","unstructured":"Reischig T, Opatrny K Jr, Bouda M, Treska V, Jindra P, Svecova M. A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation. Transpl Int. 2002;15(12):615\u201322.","journal-title":"Transpl Int"},{"issue":"8","key":"10671_CR23","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1097\/TXD.0000000000000678","volume":"3","author":"J Yang","year":"2017","unstructured":"Yang J, Jeong JC, Lee J, Kim YH, Paik HC, Kim JJ, Park HY, Kim MS, Ahn C. Design and Methods of the Korean Organ Transplantation Registry. Transplant Direct. 2017;3(8):e191.","journal-title":"Transplant Direct."},{"issue":"4","key":"10671_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.23876\/j.krcp.21.185","volume":"41","author":"HJ Jeon","year":"2022","unstructured":"Jeon HJ, Koo TY, Ju MK, Chae DW, Choi SJN, Kim MS, Ryu JH, Jeon JC, Ahn C, Yang J. The Korean Organ Transplantation Registry (KOTRY): an overview and summary of the kidney-transplant cohort. Kidney Res Clin Pract. 2022;41(4):492\u2013507.","journal-title":"Kidney Res Clin Pract"},{"issue":"1","key":"10671_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, Pikis A, Razonable RR, Miller V, Griffiths PD, et al. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. Clin Infect Dis. 2017;64(1):87\u201391.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10671_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"4","key":"10671_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/rmv.655","volume":"20","author":"MJ Cannon","year":"2010","unstructured":"Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202\u201313.","journal-title":"Rev Med Virol"},{"issue":"6","key":"10671_CR28","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1681\/ASN.2004121113","volume":"16","author":"CN Kotton","year":"2005","unstructured":"Kotton CN, Fishman JA. Viral infection in the renal transplant recipient. J Am Soc Nephrol. 2005;16(6):1758\u201374.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10671_CR29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1086\/318724","volume":"32","author":"CV Paya","year":"2001","unstructured":"Paya CV. Prevention of cytomegalovirus disease in recipients of solid-organ transplants. Clin Infect Dis. 2001;32(4):596\u2013603.","journal-title":"Clin Infect Dis"},{"key":"10671_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fcimb.2020.00130","volume":"10","author":"E Forte","year":"2020","unstructured":"Forte E, Zhang Z, Thorp EB, Hummel M. Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response. Front Cell Infect Microbiol. 2020;10:130.","journal-title":"Front Cell Infect Microbiol"},{"issue":"25","key":"10671_CR31","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1056\/NEJMra064928","volume":"357","author":"JA Fishman","year":"2007","unstructured":"Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357(25):2601\u201314.","journal-title":"N Engl J Med"},{"issue":"12","key":"10671_CR32","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","volume":"4","author":"MK Gandhi","year":"2004","unstructured":"Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004;4(12):725\u201338.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10671_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","volume":"45","author":"P Ramanan","year":"2013","unstructured":"Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ transplantation: a review. Infect Chemother. 2013;45(3):260\u201371.","journal-title":"Infect Chemother"},{"issue":"5","key":"10671_CR34","doi-asserted-by":"publisher","first-page":"e5512","DOI":"10.1371\/journal.pone.0005512","volume":"4","author":"AC Kalil","year":"2009","unstructured":"Kalil AC, Freifeld AG, Lyden ER, Stoner JA. Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy. PLoS One. 2009;4(5):e5512.","journal-title":"PLoS One."},{"issue":"8","key":"10671_CR35","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/sj.ki.5002464","volume":"72","author":"S Dmitrienko","year":"2007","unstructured":"Dmitrienko S, Yu A, Balshaw R, Shapiro RJ, Keown PA, Genome Canada Biomarkers in Transplantation G. The use of consensus guidelines for management of cytomegalovirus infection in renal transplantation. Kidney Int. 2007;72(8):1014\u201322.","journal-title":"Kidney Int"},{"issue":"1","key":"10671_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-6143.2007.02031.x","volume":"8","author":"T Reischig","year":"2008","unstructured":"Reischig T, Jindra P, Hes O, Svecova M, Klaboch J, Treska V. Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. Am J Transplant. 2008;8(1):69\u201377.","journal-title":"Am J Transplant"},{"issue":"6","key":"10671_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000335962","volume":"35","author":"L Kielberger","year":"2012","unstructured":"Kielberger L, Bouda M, Jindra P, Reischig T. Pharmacoeconomic impact of different regimens to prevent cytomegalovirus infection in renal transplant recipients. Kidney Blood Press Res. 2012;35(6):407\u201316.","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"10671_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/01.TP.0000150024.01672.CA","volume":"79","author":"T Reischig","year":"2005","unstructured":"Reischig T, Jindra P, Mares J, Cechura M, Svecova M, Hes O, Opatrny K Jr, Treska V. Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection. Transplantation. 2005;79(3):317\u201324.","journal-title":"Transplantation"},{"issue":"1","key":"10671_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4285\/kjt.2020.34.1.15","volume":"34","author":"WY Park","year":"2020","unstructured":"Park WY, Kim Y, Paek JH, Jin K, Park SB, Han S. Effectiveness of valacyclovir prophylaxis against the occurrence of cytomegalovirus infection in kidney transplant recipients. Korean J Transplant. 2020;34(1):15\u201323.","journal-title":"Korean J Transplant"},{"issue":"1","key":"10671_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12941-020-00372-0","volume":"19","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhou T, Huang M, Gu G, Xia Q. Prevention of cytomegalovirus infection after solid organ transplantation: a Bayesian network analysis. Ann Clin Microbiol Antimicrob. 2020;19(1):34.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"187","key":"10671_CR41","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.24976\/Discov.Med.202436187.150","volume":"36","author":"E Aydemir","year":"2024","unstructured":"Aydemir E. Anti-Inflammatory Immunomodulatory Activity of Valacyclovir on the in Vitro Activated Mammalian Macrophages. Discov Med. 2024;36(187):1641\u20137.","journal-title":"Discov Med"},{"issue":"1","key":"10671_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1017\/S0950268808000551","volume":"137","author":"JB Dowd","year":"2009","unstructured":"Dowd JB, Aiello AE, Alley DE. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol Infect. 2009;137(1):58\u201365.","journal-title":"Epidemiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10671-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10671-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10671-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T10:21:51Z","timestamp":1741170111000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10671-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10671"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10671-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Institutional Review Board of each center and the National Evidence-based Healthcare Collaborating Agency (NECA-IRB number: NECAIRB21-002). The need for informed consent was waived by the Institutional Review Board of each center (Kyung Hee University Hospital, Kyung Hee University Hospital at Gangdong, Seoul St. Mary's Hospital, Korea University Anam Hospital, Kyungpook National University Hospital, Keimyung University Dongsan Hospital, Pusan National University Hospital, Seoul National University Bundang Hospital, Seoul National University Hospital, Severance Hospital, CHA Bundang Medical Center, Samsung Medical Center, Soonchunhyang University Seoul Hospital, Inje University Busan Paik Hospital, Chonnam National University Hospital, Kangdong Sacred Heart Hospital, Incheon St. Mary's Hospital, Wonju Severance Christian Hospital, Kosin University Gospel Hospital, Eunpyeong St. Mary's Hospital) and the National Evidence-based Healthcare Collaborating Agency.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not application.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}